课题基金 / 基金详情

Role of Chitinase-3-like 3 protein in endogenous oligodendrogenesis and remyelination during experimental multiple sclerosis

Role of Chitinase-3-like 3 protein in endogenous oligodendrogenesis and remyelination during experimental multiple sclerosis
几丁质酶 3 样 3 蛋白在实验性多发性硬化症内源性少突胶质细胞发生和髓鞘再生中的作用
批准号:
405224879
负责人:
Dr. Sarah C Staroßom
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2023-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
在脱髓鞘疾病中,如多发性硬化症(MS)及其小鼠模型实验性自身免疫性脑脊髓炎(EAE),少突胶质细胞发生和再髓鞘形成的失败会导致慢性脱髓鞘和轴突变性,导致毁灭性的残疾。因此,了解推动少突胶质细胞发生的分子和细胞机制对于开发重新髓鞘的治疗策略至关重要。尽管重新髓鞘形成长期以来一直被认为是由实质少突胶质前体细胞(POPSc)驱动的,但我们和其他人已经证明,如果局部微环境允许,来自脑室下区的成人神经干细胞(NSCs)在脱髓鞘时被激活,并对髓鞘修复做出显著贡献。我们已经证明了几丁质酶-3-样-3(Chi313),也被称为YM1,形成了这种允许的局部微环境的一部分,并通过激活神经干细胞和OPC来诱导髓鞘少突胶质细胞的产生。此外,我们还发现,抑制内源性Chi313的表达会加重疾病的严重程度,并减少EAE的少突胶质细胞形成和再髓鞘形成。我们的结果表明,Chi3l3是一种迄今未知的内源性诱导物,可用于少突胶质细胞的命运选择和髓鞘再分化。这就提出了一个问题,即Chi3l3的治疗应用是否可以调节不同疾病阶段的少突胶质细胞发生、再髓鞘形成和临床症状,以及神经干细胞驱动的修复-相对于pOPC驱动的修复-在多大程度上有助于临床变化。为了研究这些问题,我在这里的目的是在复发缓解型EAE的不同阶段应用Chi3l3治疗,并随后结合免疫组织化学/共聚焦分析和流式细胞术分析内源性修复。野生型SJL小鼠的使用将使我们能够详细描述NSC和OPC驱动的少突胶质细胞发生/再髓鞘形成及其与临床疾病调控的相关性。Nestin-HSVtk SJL小鼠是一种在体内有条件地耗尽神经干细胞的工具,它的额外使用将允许在非操作和治疗条件下,NSC驱动的功能性髓鞘再分化与临床症状变化之间的因果联系。通过这种方式,我将描述Chi3l3的治疗潜力和潜在的细胞修复机制,最终目标是开发有效的MS和其他脱髓鞘疾病的再髓鞘疗法。
英文摘要
In demyelinating diseases, such as multiple sclerosis (MS) and its mouse model experimental autoimmune encephalomyelitis (EAE), failure of oligodendrogenesis and remyelination result in chronic demyelination and axon degeneration, causing devastating disabilities. Thus, understanding the molecular and cellular mechanisms that drive oligodendrogenesis is crucial for developing therapeutic strategies for remyelination.Although remyelination has long been considered to be driven by parenchymal oligodendrocyte precursor cells (pOPSc), we and others have shown that adult neural stem cells (NSCs) from the subventricular zone get activated in response to demyelination and significantly contribute to myelin repair, if local microenvironments allow. We have demonstrated that Chitinase-3-like-3 (Chi3l3), also known as Ym1, forms part of this permissive local microenvironment and induces the generation of myelinating oligodendrocytes by activating both neural stem cells and OPCs. Additionally, we have shown that silencing endogenous Chi3l3 expression aggravates disease severity and reduced oligodendrogenesis and remyelination in EAE. Our results show that Chi3l3 constitutes an hitherto unknown intrinsic inductor for oligodendrogenic fate choice and remyelination. This raises the question as to whether therapeutic application of Chi3l3 can be used to modulate oligodendrogenesis, remyelination and clinical symptoms in different disease phases and to which extent neural stem cell-driven repair – in contrast to pOPC driven repair- contributes to clinical changes.To investigate these questions, I aim here to apply Chi3l3-treatment in different phases of the relapsing-remitting EAE, and subsequently analyze endogenous repair by a combination of immunohistochemical/ confocal analysis and flow cytometry. The use of wild type SJL mice will allow the detailed characterization of NSC- and OPC- driven oligodendrogenesis/remyelination and its correlation to clinical disease modulation. The additional use of Nestin-HSVTK SJL mice, a tool for conditional depletion of NSCs in vivo, will allow the causal link between NSC-driven functional remyelination and changes in clinical symptoms, both under non-manipulated and therapeutic conditions. This way I will delineate the therapeutic potential of Chi3l3 and the underlying cellular mechanism of repair with the ultimate goal to develop effective remyelinating therapies for MS and other demyelinating disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
玉米大斑病菌双顺反子CDK1-CHITINASE调控附着胞发育的分子机制
  • 批准号:
    32402304
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2024
  • 负责人:
    李盼
  • 依托单位:
高温与低氧胁迫通过Hif-1/Chitinase通路影响克氏原螯虾蜕皮生长的作用及其机制